| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Small Business > EU Competition Policy Lies In Tatters |
|
Useful Advices - EU Competition Policy Lies In Tatters
The U.K. has long been following EU Competition rules to the letter allowing fully open opportunities for foreign ownership of its utilities. So much so that there are o According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product nly two major British owned gas and electricity suppliers left, namely Centrica and Scottish and Southern Energy both of which have not escaped recent rumours of foreign ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in takeover. However, it would appear that when Europe talks about fully open and integrated markets it really means open for some but closed for others. Neelie Kroes , lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. the European Competition Commissioner, made it clear that she would not tolerate the lack of cross-border competition in mainland Europe yet when she proposed that the o here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe nly real solution to this problem was a break-up of the giant European utilities she was forced to accept a watered down version under severe pressure from the German an d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro d French governments. Others, such as the Spanish, have not been quite so keen as the British to take the competition rules literally. So it was perfectly O.K. for Span ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ish company Iberdrola to take over Scottish Power but when the German giant Eon began to make moves for Endesa the protectionist tendancy of the Spanish government began easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi to rear its ugly head. Despite the Spanish government being found guilty by the European Commission of imposing totally unfair conditions on Eon’s takeover bid Spanish c nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ompany Acciona along with Italy’s Enel were able to conjure up a deal that would send Eon off with its tail between its legs. But if Italy's Enel thought that it would b and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ e able to take control of Endesa through the back door it must think again as Spain is busy putting together further nationalistic obstacles which will restrict its futu ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi re business options. I find it difficult to comprehend why German, French and Spanish governments who could all be classed at least one notch above the U.K. on the Euro ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a phile scale still insist on protectionism whenever their national energy suppliers are threatened with foreign takeover or a foreign energy company is seeking to gain en dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod try into their markets. All that we ask is for a level playing field. If European legislation prohibits protectionist policies then all member states should abide by t cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin he same rules. The additional benefits to be gained by full European co-operation massively outweigh any sacrifice at national level. By fully opening European energy ma tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen kets, for example, the status quo of having the price of gas pegged to the price of oil, for decades an added burden on European industry, could be altered in an instanc t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel e enabling Europeans to compete far more favourably in global economies. And Spain has been active in other sectors too with recent takeovers of Abbey National and BAA ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust in the U.K.. Part of the reason for such acquisitive behaviour lies in the tax breaks that are available to Spanish companies who buy abroad but are unavailable to other y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products E.C. companies. The downside of all this concentration fever in mainland Europe is that those who lose out must look elsewhere to fulfil their expansionist plans and t . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de here’s no easier location than the U.K., even when only two major indigenous gas and electricity companies remain. It’s not surprising then, that some analysts are sugg elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip esting that after its failed attempts to take over Scottish Power and then Endesa Eon may now turn its attention to Scottish and Southern Energy – and then there was one tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Is Now the Right Time to Become An Entrepreneur? Hints and Tips on Getting Publicity for Events
|